JG
TNGX icon

Jain Global’s Tango Therapeutics TNGX Stock Holding History

Jain Global’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$323K Sell
10,335
-10,035
-49% -$248K ﹤0.01% 1354
2026
Q1 		$426K Buy
+20,370
New +$284K ﹤0.01% 962
2025
Q2 		– Sell
-30,303
Closed -$41.5K – 1612
2025
Q1 		$41.5K Sell
30,303
-19,489
-39% -$47.9K ﹤0.01% 1017
2024
Q4 		$154K Buy
+49,792
New +$231K ﹤0.01% 666

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Jain Global's TNGX Position: Q2 2026 in Review

Jain Global reduced its Tango Therapeutics (TNGX) stake by 49% in Q2 2026, selling an estimated $248K and leaving 10,335 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #1354.

Jain Global first reported a position in TNGX in Q4 2024 and has held it in 4 quarters since. The position peaked at $426K in Q1 2026. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Jain Global held 10,335 shares of Tango Therapeutics worth $323K as of Q2 2026.
  • Jain Global sold 10,035 Tango Therapeutics shares in Q2 2026, an estimated $248K.
  • Tango Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1354 holding.
  • Jain Global first reported a position in Tango Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • Jain Global's Tango Therapeutics position peaked at $426K in Q1 2026.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.